Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2013
01/01/2013US8343496 Anti-CD74 immunoconjugates and methods
01/01/2013US8343494 Antibodies against LLG polypeptides of the triacylglycerol lipase family
01/01/2013US8343493 Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs
01/01/2013US8343492 Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies
01/01/2013US8343488 Diagnosis and treatment of human dormancy-related sequellae
01/01/2013US8343461 Molecular signature of cancer
01/01/2013US8343443 Fluid processing and transfer using inter-connected multi-chamber device
01/01/2013US8343428 Microchip and method of using the same
01/01/2013US8343427 Biosensor
01/01/2013US8343122 Device for monitoring a patient for a urinary tract infection
01/01/2013US8343075 Tissue penetration device
12/2012
12/27/2012WO2012178166A1 Method and apparatus for fractionating genetically distinct cells and cellular components
12/27/2012WO2012178095A1 Electromotive system for high-throughput screening
12/27/2012WO2012178087A1 Methods and compositions for the treatment and diagnosis of bladder cancer
12/27/2012WO2012178083A1 Methods of treating chronic disorders with complement inhibitors
12/27/2012WO2012178079A1 Monitoring protein trafficking using beta-galactosidase reporter fragment complementation
12/27/2012WO2012178074A1 Methods and compositions for detecting gastrointestinal and other cancers
12/27/2012WO2012178069A1 System and device for characterizing cells
12/27/2012WO2012178058A1 Compositions for and methods of detecting, diagnosing and prognosing thymic cancer
12/27/2012WO2012178030A2 Accurate measurement of glutathione for disease diagnosis and drug metabolite screening
12/27/2012WO2012178023A1 Identifying peptides at the single molecule level
12/27/2012WO2012177997A1 Treatment of proteinopathies
12/27/2012WO2012177945A2 Diagnostic methods for eosinophilic esophagitis
12/27/2012WO2012177941A1 Tissue processing apparatus and method
12/27/2012WO2012177940A2 Microfluidic devices and methods for separating and detecting constituents in a fluid sample
12/27/2012WO2012177908A1 Test unit cartridge for analyte testing device
12/27/2012WO2012177755A1 Methods and systems for the rapid characterization of functional biological molecules
12/27/2012WO2012177732A2 Measurement of formation porosity using a single gamma ray detector
12/27/2012WO2012177717A1 Diagnosis and prognosis of renal injury and renal failure
12/27/2012WO2012177684A2 Use of caspase 3 activity and its inhibitors
12/27/2012WO2012177658A2 Methods of treating and preventing staphylococcus aureus infections and associated conditions
12/27/2012WO2012177656A2 Devices, solutions and methods for sample collection
12/27/2012WO2012177647A2 Mycotoxin diagnostics and methods thereof
12/27/2012WO2012177610A1 Methods for determining methanol content in crude oils
12/27/2012WO2012177595A1 Compositions and methods for the therapy and diagnosis of cancer
12/27/2012WO2012177528A1 Self-calibrating sensor, system, and computer program product
12/27/2012WO2012177472A2 Online monitoring of contaminants in crude and heavy fuels, and refinery applications thereof
12/27/2012WO2012177106A2 Probe for ifret and usage of same
12/27/2012WO2012176977A2 Microscope apparatus for detecting or imaging protein using ifret probe, and method for detecting or imaging protein using same
12/27/2012WO2012176879A1 Reagent for cancer testing, and cancer testing method
12/27/2012WO2012176783A1 Light measurement device, light measurement method, and light measurement program
12/27/2012WO2012176775A1 Light measurement device, light measurement method, and light measurement program
12/27/2012WO2012176765A1 Anti-human p-cadherin (cdh3) recombinant antibody
12/27/2012WO2012176202A1 Articles and methods for monitoring urinary tract infection
12/27/2012WO2012176181A1 Image guided radiation therapy
12/27/2012WO2012176129A2 Matrix permittivity determination
12/27/2012WO2012176047A1 Continuous monitoring of glucose and other living body constituents
12/27/2012WO2012175976A1 Matric potential sensor and related methods
12/27/2012WO2012175797A1 In vitro cardiovascular model
12/27/2012WO2012175676A2 Molecules specifically binding pancreatic beta cells biomarkers
12/27/2012WO2012175674A1 Diagnosis and/or prognosis of a neurodegenerative disease
12/27/2012WO2012175672A2 Diagnosis and/or prognosis of parkinson's disease dementia
12/27/2012WO2012175671A1 Kit for detecting biofilms
12/27/2012WO2012175616A1 Competitive s100a9 immunoassays
12/27/2012WO2012175602A2 Elisa for calprotectin
12/27/2012WO2012175519A1 A method for detecting and/or quantifying carbonylated proteins
12/27/2012WO2012175481A1 Compositions and methods for treating leukemia
12/27/2012WO2012175458A1 A method for the identification of beta-sheet aggregated protein ligands
12/27/2012WO2012175454A2 In vitro assay method using immunological technique
12/27/2012WO2012175374A1 Background-free magnetic flow cytometry
12/27/2012WO2012175214A1 Liquid crystal based sensor devices for detecting binding events or analytes at interfaces
12/27/2012WO2012175201A1 Methods for the characterization of antibodies
12/27/2012WO2012175183A1 Determination of direct thrombin inhibitors in fluids like serum or urine
12/27/2012WO2012174978A1 Strain improvement and process optimization in two-step mixed fermentation for production of vitamin c
12/27/2012WO2012174970A1 Use of pigr as molecular marker in early recurrence and/or metastasis of tumours and intervention target for anti-metastatic drugs
12/27/2012WO2012174723A1 Risk assessment for phenytoin-induced adverse drug reactions
12/27/2012WO2012174666A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
12/27/2012WO2012154511A3 Method and device for statistical tissue sampling using microdevices
12/27/2012WO2012143370A3 Electrochemical biosensor based on hollow coils
12/27/2012WO2012142246A3 Rapid test for detection of infection and therapeutic response
12/27/2012WO2012138745A3 Pharmacogenetic test for anti-resorptive therapy-associated osteonecrosis of the jaw
12/27/2012WO2012135030A3 Combined hydrogen and pressure sensor assembly
12/27/2012WO2012135017A3 Combination of hydrogen and pressure sensors
12/27/2012WO2012135012A3 Combined hydrogen and pressure sensor assembly
12/27/2012WO2012134416A3 Peptide ligands
12/27/2012WO2012134262A3 A method for extracting protein from pectin rich plant material
12/27/2012WO2012129488A3 Gene signatures associated with rejection or recurrence of cancer
12/27/2012WO2012129242A3 Isolation of polymerase-nucleic acid complexes and loading onto substrates
12/27/2012WO2012129237A3 Therapeutic agent for emphysema and copd
12/27/2012WO2012125807A3 Systems and compositions for diagnosing barrett's esophagus and methods of using the same
12/27/2012WO2012125805A3 Protein biomarkers for the diagnosis of prostate cancer
12/27/2012WO2012125712A3 Lung tumor classifier for current and former smokers
12/27/2012WO2012124998A3 Bio-pin
12/27/2012WO2012124968A3 Method of identifying nucleic acid-containing object
12/27/2012WO2012123882A3 Examination of porosity by nmr and intrusion porosimetry
12/27/2012WO2012123863A3 Examining porous samples
12/27/2012WO2012122302A3 Methods, apparatuses, and systems for detecting and quantifying phosphoproteins
12/27/2012WO2012122015A3 Selective inhibitors of tumor-initiating cells
12/27/2012WO2012121978A3 Biomarkers for the diagnosis of lacunar stroke
12/27/2012WO2012118969A3 Method of selecting cancer patients for anti-angiogenesis therapy in combination with chemotherapy
12/27/2012WO2012109230A4 Apparatus and method for analyzing aggregate
12/27/2012WO2012104585A3 Diagnostic method
12/27/2012WO2012102535A3 Composition for detecting proteins containing tyrosine oxide-coupled biomaterial
12/27/2012WO2012099721A3 Real-time adaptive immune system and method
12/27/2012WO2012083260A3 Methods and apparatus for enhanced recovery of cells and of cell-enriched matrix from tissue samples
12/27/2012WO2012075243A3 Methods and compositions for targeting sites of neovascular growth
12/27/2012WO2012071371A3 Compositions and methods for functional glycomics
12/27/2012WO2012068499A4 Hybrid, planar optofluidic integration
12/27/2012WO2012058642A3 Use of sam68 for modulating signaling through the tnf receptor
12/27/2012WO2012054648A3 Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity
1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 3937